ICON Public Limited Company (ICLR) Stock Forecast, Price Target & Predictions
ICLR Stock Forecast
ICON Public Limited Company stock forecast is as follows: an average price target of $337.00 (represents a 62.40% upside from ICLR’s last price of $207.51) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
ICLR Price Target
ICLR Analyst Ratings
Buy
ICON Public Limited Company Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 28, 2024 | Jailendra Singh | Truist Financial | $295.00 | $229.12 | 28.75% | 42.16% |
Oct 24, 2024 | Michael Cherny | Leerink Partners | $376.00 | $280.76 | 33.92% | 81.20% |
Oct 14, 2024 | Jailendra Singh | Truist Financial | $363.00 | $295.45 | 22.86% | 74.93% |
Sep 20, 2024 | Eric Coldwell | Robert W. Baird | $340.00 | $300.92 | 12.99% | 63.85% |
Sep 18, 2024 | Michael Cherny | Leerink Partners | $379.00 | $292.54 | 29.55% | 82.64% |
Jul 08, 2024 | Eric Coldwell | Robert W. Baird | $376.00 | $319.70 | 17.61% | 81.20% |
Jun 06, 2024 | Matthew Sykes | Goldman Sachs | $370.00 | $329.65 | 12.24% | 78.30% |
May 31, 2024 | Eric Coldwell | Robert W. Baird | $367.00 | $322.92 | 13.65% | 76.86% |
May 31, 2024 | David Windley | Jefferies | $390.00 | $322.92 | 20.77% | 87.94% |
May 30, 2024 | Elizabeth Anderson | Evercore ISI | $360.00 | $322.92 | 11.48% | 73.49% |
Oct 06, 2022 | Luke Sergott | Barclays | $215.00 | $197.22 | 9.02% | 3.61% |
Apr 25, 2022 | Wells Fargo | $250.00 | $233.95 | 6.86% | 20.48% | |
Aug 04, 2021 | Katie Tryhane | Credit Suisse | $250.00 | $246.07 | 1.60% | 20.48% |
Jul 23, 2021 | Dan Leonard | Wells Fargo | $280.00 | $218.00 | 28.44% | 34.93% |
Jul 20, 2021 | Erin Wright | Morgan Stanley | $250.00 | $215.88 | 15.81% | 20.48% |
ICON Public Limited Company Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 5 | 10 |
Avg Price Target | - | $350.60 | $361.60 |
Last Closing Price | $207.51 | $207.51 | $207.51 |
Upside/Downside | -100.00% | 68.96% | 74.26% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 24, 2024 | Leerink Partners | Outperform | Outperform | Hold |
Sep 18, 2024 | Leerink Partners | Outperform | Initialise | |
Jun 06, 2024 | Goldman Sachs | Buy | Initialise | |
May 31, 2024 | Cowen & Co. | Buy | Buy | Hold |
May 31, 2024 | Jefferies | Buy | Buy | Hold |
May 30, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Jan 13, 2023 | Barclays | Equal-Weight | Overweight | Upgrade |
Nov 09, 2022 | Bank of America Securities | Buy | Upgrade | |
Feb 25, 2022 | Deutsche Bank | Hold | Hold | Hold |
Feb 23, 2022 | Citigroup | Buy | Buy | Hold |
Feb 23, 2022 | Barclays | Equal-Weight | Equal-Weight | Hold |
ICON Public Limited Company Financial Forecast
ICON Public Limited Company Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.98B | $1.96B | $1.94B | $1.94B | $1.90B | $1.89B | $1.87B | $871.15M | $858.20M | $760.23M | $701.73M | $620.23M | $715.10M | $725.41M | $710.44M |
Avg Forecast | $2.34B | $2.30B | $2.25B | $2.21B | $2.16B | $2.14B | $2.12B | $2.08B | $2.03B | $2.13B | $2.14B | $2.09B | $2.09B | $2.05B | $2.02B | $1.98B | $1.96B | $1.94B | $1.93B | $1.89B | $1.90B | $1.84B | $857.67M | $788.29M | $751.17M | $662.45M | $598.76M | $706.63M | $734.17M | $709.66M |
High Forecast | $2.36B | $2.32B | $2.28B | $2.24B | $2.19B | $2.16B | $2.14B | $2.09B | $2.04B | $2.14B | $2.14B | $2.09B | $2.11B | $2.07B | $2.04B | $2.00B | $1.98B | $1.94B | $1.93B | $1.89B | $1.90B | $1.84B | $857.67M | $788.29M | $751.17M | $662.45M | $598.76M | $706.63M | $734.17M | $709.66M |
Low Forecast | $2.31B | $2.27B | $2.23B | $2.18B | $2.14B | $2.11B | $2.09B | $2.07B | $1.99B | $2.13B | $2.14B | $2.09B | $2.08B | $2.03B | $1.99B | $1.95B | $1.94B | $1.94B | $1.93B | $1.89B | $1.90B | $1.84B | $857.67M | $788.29M | $751.17M | $662.45M | $598.76M | $706.63M | $734.17M | $709.66M |
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 4 | 4 | 5 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 5 | 9 | 6 | 4 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.00% | 1.00% | 1.00% | 1.01% | 0.99% | 1.01% | 1.02% | 1.09% | 1.01% | 1.06% | 1.04% | 1.01% | 0.99% | 1.00% |
Forecast
ICON Public Limited Company EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 4 | 4 | 5 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 5 | 9 | 6 | 4 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $384.10M | $355.19M | $401.24M | $353.34M | $328.16M | $236.57M | $301.75M | $130.33M | $133.68M | $137.21M | $125.47M | $91.34M | $124.42M | $132.52M | $134.87M |
Avg Forecast | $406.38M | $398.98M | $391.97M | $384.64M | $376.07M | $371.17M | $368.43M | $361.88M | $353.18M | $371.01M | $371.48M | $368.05M | $363.39M | $356.90M | $350.82M | $334.59M | $310.76M | $353.42M | $352.01M | $304.17M | $346.20M | $336.62M | $156.62M | $127.31M | $137.17M | $120.97M | $109.34M | $122.32M | $134.07M | $129.59M |
High Forecast | $410.50M | $403.02M | $395.94M | $388.54M | $379.88M | $374.93M | $372.16M | $363.64M | $354.92M | $371.24M | $371.48M | $441.66M | $366.89M | $359.61M | $354.37M | $401.51M | $372.91M | $353.42M | $352.01M | $365.01M | $346.20M | $336.62M | $156.62M | $152.77M | $137.17M | $120.97M | $109.34M | $146.78M | $134.07M | $129.59M |
Low Forecast | $401.15M | $393.83M | $386.92M | $379.68M | $371.22M | $366.38M | $363.68M | $360.13M | $346.23M | $370.78M | $371.48M | $294.44M | $361.65M | $352.63M | $346.30M | $267.67M | $248.61M | $353.42M | $352.01M | $243.34M | $346.20M | $336.62M | $156.62M | $101.85M | $137.17M | $120.97M | $109.34M | $97.85M | $134.07M | $129.59M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.15% | 1.14% | 1.14% | 1.00% | 1.08% | 0.68% | 0.90% | 0.83% | 1.05% | 1.00% | 1.04% | 0.84% | 1.02% | 0.99% | 1.04% |
Forecast
ICON Public Limited Company Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 4 | 4 | 5 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 5 | 9 | 6 | 4 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $116.65M | $117.44M | $160.15M | $115.73M | $111.97M | $77.16M | $-93.58M | $73.86M | $97.12M | $101.23M | $91.64M | $47.76M | $91.70M | $99.01M | $94.83M |
Avg Forecast | $364.04M | $351.77M | $346.10M | $335.65M | $327.71M | $316.34M | $310.56M | $298.85M | $285.49M | $321.32M | $307.27M | $132.47M | $288.68M | $273.15M | $256.67M | $120.43M | $83.79M | $245.35M | $234.11M | $109.48M | $218.51M | $199.00M | $177.78M | $92.68M | $152.87M | $126.95M | $91.44M | $90.60M | $152.68M | $145.20M |
High Forecast | $368.83M | $356.41M | $350.66M | $340.07M | $332.03M | $320.50M | $314.65M | $308.30M | $292.18M | $321.55M | $307.28M | $158.97M | $292.03M | $279.81M | $260.05M | $144.52M | $100.55M | $245.35M | $234.11M | $131.38M | $218.51M | $199.00M | $177.78M | $111.22M | $152.87M | $126.95M | $91.44M | $108.73M | $152.68M | $145.20M |
Low Forecast | $357.94M | $345.88M | $340.30M | $330.02M | $322.22M | $311.04M | $305.36M | $287.69M | $271.25M | $321.10M | $307.26M | $105.98M | $285.32M | $267.32M | $252.37M | $96.34M | $67.03M | $245.35M | $234.11M | $87.59M | $218.51M | $199.00M | $177.78M | $74.15M | $152.87M | $126.95M | $91.44M | $72.48M | $152.68M | $145.20M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 1.40% | 0.65% | 0.49% | 1.02% | 0.35% | -0.47% | 0.42% | 1.05% | 0.66% | 0.72% | 0.52% | 1.01% | 0.65% | 0.65% |
Forecast
ICON Public Limited Company SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 4 | 4 | 5 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 5 | 9 | 6 | 4 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $200.01M | $226.75M | $166.79M | $189.95M | $195.26M | $202.72M | $206.71M | $109.88M | $98.53M | $87.88M | $83.12M | $83.50M | $87.20M | $86.18M | $85.45M |
Avg Forecast | $254.91M | $250.26M | $245.86M | $241.27M | $235.89M | $232.81M | $231.10M | $226.99M | $221.54M | $232.72M | $233.01M | $231.02M | $227.94M | $223.87M | $220.05M | $210.01M | $222.14M | $210.04M | $209.20M | $190.92M | $205.74M | $200.05M | $93.08M | $94.03M | $81.52M | $71.89M | $64.98M | $86.16M | $79.67M | $77.01M |
High Forecast | $257.49M | $252.79M | $248.35M | $243.71M | $238.28M | $235.17M | $233.44M | $228.09M | $222.63M | $232.86M | $233.01M | $277.22M | $230.13M | $225.57M | $222.28M | $252.02M | $266.56M | $210.04M | $209.20M | $229.11M | $205.74M | $200.05M | $93.08M | $112.84M | $81.52M | $71.89M | $64.98M | $103.39M | $79.67M | $77.01M |
Low Forecast | $251.62M | $247.03M | $242.69M | $238.16M | $232.85M | $229.81M | $228.12M | $225.89M | $217.17M | $232.57M | $233.01M | $184.81M | $226.84M | $221.19M | $217.21M | $168.01M | $177.71M | $210.04M | $209.20M | $152.74M | $205.74M | $200.05M | $93.08M | $75.23M | $81.52M | $71.89M | $64.98M | $68.93M | $79.67M | $77.01M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 1.02% | 0.79% | 0.91% | 1.02% | 0.99% | 1.03% | 1.18% | 1.05% | 1.08% | 1.16% | 1.29% | 1.01% | 1.08% | 1.11% |
Forecast
ICON Public Limited Company EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 6 | 10 | 9 | 4 | 4 | 5 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 5 | 9 | 6 | 4 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.43 | $1.44 | $1.96 | $1.42 | $1.37 | $0.95 | $-1.16 | $1.40 | $1.84 | $1.92 | $1.74 | $0.91 | $1.63 | $1.78 | $1.73 |
Avg Forecast | $4.36 | $4.22 | $4.15 | $4.02 | $3.93 | $3.79 | $3.72 | $3.58 | $3.42 | $3.85 | $3.68 | $3.41 | $3.46 | $3.27 | $3.08 | $2.88 | $3.07 | $2.94 | $2.81 | $2.69 | $2.62 | $2.39 | $2.13 | $1.97 | $1.83 | $1.52 | $1.10 | $1.68 | $1.83 | $1.74 |
High Forecast | $4.42 | $4.27 | $4.20 | $4.08 | $3.98 | $3.84 | $3.77 | $3.69 | $3.50 | $3.85 | $3.68 | $3.41 | $3.50 | $3.35 | $3.12 | $2.91 | $3.11 | $2.94 | $2.81 | $2.69 | $2.62 | $2.39 | $2.13 | $1.97 | $1.83 | $1.52 | $1.10 | $1.68 | $1.83 | $1.74 |
Low Forecast | $4.29 | $4.14 | $4.08 | $3.95 | $3.86 | $3.73 | $3.66 | $3.45 | $3.25 | $3.85 | $3.68 | $3.41 | $3.42 | $3.20 | $3.02 | $2.83 | $3.01 | $2.94 | $2.81 | $2.69 | $2.62 | $2.39 | $2.13 | $1.97 | $1.83 | $1.52 | $1.10 | $1.68 | $1.83 | $1.74 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.50% | 0.47% | 0.67% | 0.51% | 0.51% | 0.36% | -0.49% | 0.66% | 0.93% | 1.05% | 1.14% | 0.83% | 0.97% | 0.97% | 0.99% |
Forecast
ICON Public Limited Company Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ICLR | ICON Public Limited Company | $203.26 | $337.00 | 65.80% | Buy |
NEOG | Neogen | $12.13 | $17.50 | 44.27% | Buy |
IQV | IQVIA | $196.64 | $252.80 | 28.56% | Buy |
MTD | Mettler-Toledo | $1.25K | $1.41K | 13.28% | Hold |
LH | Laboratory Corporation of America | $230.95 | $258.20 | 11.80% | Buy |
CRL | Charles River Laboratories | $189.33 | $209.00 | 10.39% | Buy |
QGEN | Qiagen | $45.34 | $48.33 | 6.59% | Buy |
MEDP | Medpace | $348.48 | $369.67 | 6.08% | Hold |
WAT | Waters | $373.72 | $356.80 | -4.53% | Buy |
TWST | Twist Bioscience | $48.40 | $46.00 | -4.96% | Buy |